This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEE6P1NM_M.jpg
Bristol Myers will pay $225 per share in cash, a 61.2% premium to MyoKardia’s Friday closing price.
Bristol-Myers to buy heart drugs developer MyoKardia for about $13 billion
4 years ago
No Comments
Related Posts
Juggernauts grab spotlight from jumbos at Dubai Airshow
November 14, 2021
Some bloodstream infection bacteria grew resistant to last-resort drugs in 2020 – WHO
December 9, 2022
Tesco raises outlook and will buyback shares after strong first half
October 6, 2021
French fashion company SMCP’s sales near pre-pandemic levels
October 27, 2021
Exclusive-Altria-backed cannabis producer Cronos explores sale -sources
July 6, 2023
Monte dei Paschi considers subordinated debt issue to win ECB nod on bad loans: report
August 6, 2020
About The Author
